Trademarkia Logo

Canada

C$
CAR T TOGETHER
REGISTERED

on 3 Jan 2025

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

Allogene Therapeutics, Inc.

210 E. Grand AvenueSouth San Francisco CA 94080

US

Serial Number

2262405 filed on 2th Feb 2023

Registration Number

TMA1281381 registered on 3rd Jan 2025

Registration expiry Date

2th Feb 2033

Correspondent Address

CLARK WILSON LLP

900 - 885 WEST GEORGIA STREETVANCOUVER

BRITISH COLUMBIA

CA

V6C3H1

CAR T TOGETHER

Trademark usage description

printed publications, namely, pamphlets and brochures about research, detection, diagnosis, and medical treatments in the fields of pharmaceuticals, c Read More

Classification Information


Class [016]
Printed publications, namely, pamphlets and brochures about research, detection, diagnosis, and medical treatments in the fields of pharmaceuticals, cell therapies, chimeric antigen receptor T cell therapy, oncology, and cancer.


Classification kind code

12

Class [035]
Promoting public awareness about cancer; promoting public awareness about chimeric antigen receptor T cell therapy; promoting public awareness about research, detection, diagnosis, and medical treatments in the fields of pharmaceuticals, cell therapies, chimeric antigen receptor T cell therapy, oncology, and cancer.


Classification kind code

12

Class [041]
Providing online non-downloadable publications in the nature of pamphlets, reports, articles, and brochures featuring information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy; on-line publication of electronic journals in the nature of blogs, featuring information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy.


Classification kind code

12

Class [042]
Providing information about medical research in the field of cancer; providing information about medical research in the field of chimeric antigen receptor T cell therapy; medical and scientific research in the field of cancer treatment and chimeric antigen receptor T cell therapy.


Classification kind code

12

Class [044]
Providing medical information in the field of cancer; providing medical information in the field of chimeric antigen receptor T cell therapy; providing medical information in the form of reports in the field of immunotherapy and cancer treatment; providing medical information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy via a website; providing medical information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy via an internet website portal.


Classification kind code

12

Mark Details


Serial Number

2262405

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 18th Sept 2024
Approved
Submitted for opposition 27
on 18th Sept 2024
Approval Notice Sent
Submitted for opposition 22
on 10th Sept 2024
Search Recorded
Submitted for opposition 256
on 8th Apr 2024
Notification of Possible Opposition Sent
Submitted for opposition 48
on 19th Jul 2023
Agent Changed
Submitted for opposition 257
on 8th Jun 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 7th Jun 2023
Formalized
Submitted for opposition 1
on 7th Jun 2023
Created
Submitted for opposition 228
on 2th Feb 2023
International Registration
Submitted for opposition 30
on 2th Feb 2023
Filed